Today: We have the latest financial results from B Investments and Cleopatra Hospitals Group + an update from Talaat Moustafa Group & IPO news. Let's jump in

🔔 EGX30 ended -0.9% by market close on Thursday at 52,164 points, the EGX70 fell 0.7% to 15,349 points, and the EGX100 dropped 0.7% to reach 21,213 points.

💸 The number of transactions reached 213,672 spread across 3,922,116,005 stocks leading to a turnover of EGP 9.248 billion.

🏷️ Regional investors were the only net sellers. 

📈 Top gainers for the market as a whole included Lotus For Agricultural Investments And Development (+13.1%), Tycoon Holding Company For Financial Investments (+11.7%), Export Development Bank of Egypt (+7.0%).

📉 Top losers for the market included Subscription Rights Of Aspire Capital (-11.4%), Egyptian for Tourism Resorts (-11.3%), and Aspire Capital (-6.8%).

⬆️ Top gainers for EGX30 included Qalaa Holdings (+6.3%), Raya Holding (+2.3%), and Ibnsina Pharma (+1.4%).

⬇️ Top losers for EGX30 included Fawry (-4.0%), Orascom Investment Holding (-3.6%), and E-finance (-2.9%).

Other Important Stats: 

🧈 24K Gold reached EGP  7,367 per gram, down 0.4% day-on-day and down 7.8% month-on-month.

💲 The USD reached EGP 51.77 at the National Bank of Egypt.

B Investments Holding (BINV) kicked off 2026 with a sharp increase in profitability, reporting a 202.8% year-on-year rise in first-quarter net profit after tax to EGP 212.8 million, according to its latest financial statement.

Revenue also saw strong growth during the quarter, climbing to EGP 411.7 million from EGP 138.5 million in the corresponding period of 2025.

Refresher about the company:

Founded in 2006, B Investments is one of Egypt’s leading private equity and growth capital firms, with investments spanning financial services, healthcare, consumer retail, real estate, fintech, microfinance, and renewable energy.

Its portfolio includes major stakes in OB Financial Holding, Gourmet Egypt, Contact Financial Holding, El Ezaby Pharmacies, Basata, B Healthcare Investments, and Madinet Masr, as well as exposure to Tamweel Group and solar power assets in Benban.

Expansion and exit opportunities:

The strong earnings performance comes as the company pursues new investments while evaluating potential exits across its portfolio. Chairman Hazem Barakat told Al Arabiya Business that B Investments is exploring opportunities to monetize certain holdings, including potential listings on the Egyptian Exchange as market conditions improve.

Among the assets that could eventually reach the market is El Ezaby Pharmacies, which is studying a potential IPO in 2027, although plans remain at an early stage. The group is also targeting new investments valued between EGP 2 billion and EGP 3 billion during 2026.

In April, B Investments announced plans to invest EGP 560 million in European Universities in Egypt through a combination of share purchases and a capital increase, marking the firm's entry into the higher education sector.

Recent stock performance:

The company’s share price has risen 25.3% since the beginning of 2026. This makes it up 60.1% compared to levels recorded 12 months ago.

Cleopatra Hospitals Group (CLHO) reported a consolidated net profit of EGP 153 million for Q1 2026, down 34% year-on-year, according to its latest financial results.

Revenue climbs 22% in Q1 2026

Total consolidated revenue reached EGP 1.973 billion, up 22% compared with the same period last year. The increase was driven by a 9% rise in total cases served to 355,035, along with price increases and a higher-acuity case mix.

Facility performance:

Cleopatra Hospital: The group's largest contributor generated record revenue of EGP 623 million, up 19% year-on-year, accounting for 31% of consolidated revenue.

Cairo Specialized Hospital: Revenue rose 15% year-on-year to EGP 420 million, supported by growth in specialized medical services, including its bone marrow transplantation unit.

Al-Shorouk Hospital: Revenue increased 9% year-on-year to EGP 269 million, supported by the launch of renovated inpatient rooms dedicated to oncology services.

Nile Badrawi Hospital: Revenue declined 4% year-on-year to EGP 240 million, reflecting a transition within the cardiology department following the onboarding of a new medical team.

Cleopatra El Tagamoa: The hospital generated EGP 154 million in revenue during its first full quarter of operations, contributing 8% of consolidated revenue after opening in January 2026.

Cleopatra October Hospital: Revenue rose 28% year-on-year to EGP 108 million as patient activity continued to increase.

Polyclinics and other operations: El Katib Hospital generated EGP 81 million in revenue, up 6% year-on-year, while CHG for Medical Services (Polyclinics) and New Bedaya (IVF) contributed to the group's outpatient and specialized healthcare offerings.

Outlook:

The Group expects future growth to be supported by the continued ramp-up of Cleopatra El Tagamoa Hospital, which is targeting a capacity of 240 beds during 2026, as well as the planned 200-bed build-to-suit extension at Cleopatra October Hospital

Recent stock performance:

The company’s share price has risen 19.8% since the beginning of 2026. This makes it up 90.5% compared to levels recorded 12 months ago.

📝 Talaat Moustafa Group (TMGH) signed a preliminary agreement with Saudi Arabia's Public Investment Fund to explore large-scale mixed-use developments across the kingdom, spanning residential, hospitality, retail, and commercial assets. The move builds on TMG's growing Saudi footprint, where the developer is already constructing its flagship Banan project and positioning itself as a key private-sector partner in the kingdom's real estate expansion.

🏦Egypt's planned IPO of Banque du Caire has been delayed until the end of 2026 due to regional geopolitical uncertainty and seasonally weaker market activity, a senior government official told Al Arabiya. Preparations are continuing behind the scenes, with valuation work already completed and investor roadshows expected to begin in October ahead of a potential listing before year-end.

24 June:

Abu Qir Fertilizers - distribution date for EGP 1.30  per share. The record date was April 19th.

28 June:
Eastern Company - distribution date for EGP 0.45 per share. The record date was May 20th.

29 June:
Misr Cement - distribution date for EGP 5 per share. The record date was April 22nd.

💰 Egypt is preparing new legislation that could channel around EGP 37 billion annually into the state budget by requiring government-owned companies to transfer a portion of their profits to the treasury, according to an Asharq report citing a government official. The proposal forms part of a broader push to boost public revenues and comes alongside other tax measures currently under discussion, including new levies on natural gas and commercial property rentals.

📉 The Egyptian government has revised its medium-term economic roadmap, cutting its FY 2029/30 growth target to 6.8% from 7.5%, according to planning documents reviewed by EnterpriseAM. Officials cited regional conflicts, weaker Suez Canal revenues, and global economic disruptions, while still targeting higher investment levels, stronger foreign direct investment inflows, and a gradual decline in inflation over the coming years.